Adial Pharmaceuticals Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 12
Employees
  • Stock Symbol
  • ADIL
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $3.13
  • (As of Tuesday Closing)

Adial Pharmaceuticals General Information

Description

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 1180 Seminole Trail
  • Suite 495
  • Charlottesville, VA 22901
  • United States
+1 (434) 000-0000

Adial Pharmaceuticals Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Adial Pharmaceuticals Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.13 $2.87 $1.14 - $4.00 $57M 18.2M 690K -$0.94

Adial Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 37,392 17,103 16,338 30,330
Revenue 0 0 0 0
EBITDA (13,446) (10,925) (8,686) (10,471)
Net Income (13,450) (10,893) (8,591) (11,631)
Total Assets 8,625 5,491 7,680 4,699
Total Debt 313 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Adial Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Adial Pharmaceuticals‘s full profile, request access.

Request a free trial

Adial Pharmaceuticals Executive Team (11)

Name Title Board Seat Contact Info
William Stilley III Chief Executive Officer & Board Member
Joseph Truluck Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Mark Peikin JD Chief Strategy Officer
J. Kermit Anderson Director
Alex Lugovoy Chief Business Officer
You’re viewing 5 of 11 executive team members. Get the full list »

Adial Pharmaceuticals Board Members (9)

Name Representing Role Since
James Newman Jr. Adial Pharmaceuticals Board Member 000 0000
Kevin Schuyler Self Chairman 000 0000
Robertson Gilliland Adial Pharmaceuticals Board Member 000 0000
William Stilley III Adial Pharmaceuticals Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 9 board members. Get the full list »

Adial Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adial Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Adial Pharmaceuticals‘s full profile, request access.

Request a free trial

Adial Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 26-Jan-2021 000000000000000000 000.00 Drug Discovery 0000000 0000000 000
To view Adial Pharmaceuticals’s complete acquisitions history, request access »